5α-reductase Inhibition Coupled with Short Off Cycles Increases Survival in the LNCaP Xenograft Prostate Tumor Model on Intermittent Androgen Deprivation Therapy

Eitemau Tebyg

• Prolongation of Off-Cycle Interval by Finasteride Is Not Associated with Survival Improvement in Intermittent Androgen Deprivation Therapy in LNCaP Tumor Model
  gan: Wang, Yujuan, et al.
  Cyhoeddwyd: (2010)
• Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition
  gan: Byrne, N M, et al.
  Cyhoeddwyd: (2016)
• Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence
  gan: Zheng, Xi, et al.
  Cyhoeddwyd: (2010)
• Effect of curcumin on the interaction between androgen receptor and Wnt/β-catenin in LNCaP xenografts
  gan: Hong, Jeong Hee, et al.
  Cyhoeddwyd: (2015)
• Androgen deprivation causes truncation of the C‐terminal region of androgen receptor in human prostate cancer LNCaP cells
  gan: Harada, Naoki, et al.
  Cyhoeddwyd: (2012)